Quick Answer
LEMAITRE VASCULAR INC reported Operating Income Loss of $67.91 million for the year ending 2025.
- LEMAITRE VASCULAR INC showed an increase of +30.0% in Operating Income Loss from 2024 to 2025.
- This data is from LEMAITRE VASCULAR INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), LEMAITRE VASCULAR INC's Operating Income Loss has grown by 3,384.5%.
- Historical annual values: Fiscal year 2025: $67.91 million | Fiscal year 2024: $52.26 million | Fiscal year 2023: $36.71 million | Fiscal year 2022: $26.83 million | Fiscal year 2021: $36.43 million | Fiscal year 2020: $28.79 million | Fiscal year 2019: $21.18 million | Fiscal year 2018: $28.21 million | Fiscal year 2017: $21.10 million | Fiscal year 2016: $16.34 million | Fiscal year 2015: $11.51 million | Fiscal year 2014: $6.34 million | Fiscal year 2013: $4.52 million | Fiscal year 2012: $4.24 million | Fiscal year 2011: $3.69 million | Fiscal year 2010: $4.02 million | Fiscal year 2009: $1.95 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: